4:02PM ImmunoCellular Therapeutics Announces Proposed Public Offering of Common Stock and Warrants; size not disclosed (IMUC) 2.41 -0.06 : Co announced that it intends to offer shares of its common stock and warrants in an underwritten public offering. The Company also expects to grant the underwriters a 30-day option to purchase additional shares of common stock and warrants to cover over-allotments, if any. Lazard Capital Markets LLC is acting as sole book-running manager for the offering. While the offering is expected to price before 9:30 am EDT on October 18, 2012, the offering is subject to market conditions.
Market Data 
Markets 
AI
